Fukuoka, Japan

Akiyuki Nishimura

This inventor holds 1 USPTO granted patent. Top assignee: Rdiscovery, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiyuki Nishimura. Retrieved from https://idiyas.com/inventor/akiyuki-nishimura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akiyuki Nishimura: Innovator in Pharmaceutical Chemistry

Introduction

Akiyuki Nishimura is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit complex formation related to dynamin-related protein 1 (Drp1).

Latest Patents

Nishimura holds a patent for Drp1-filamin complex formation inhibitors. This patent includes compounds represented by a specific formula, along with their pharmacologically acceptable salts and solvates. The patent also covers pharmaceutical compositions and the uses of these compounds as prophylactic or therapeutic agents.

Career Highlights

Akiyuki Nishimura is associated with Rdiscovery, LLC, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, aiming to address various health challenges.

Collaborations

Nishimura collaborates with talented individuals such as Akio Ojida and Naoya Shindo. These partnerships enhance the research and development process, fostering innovation in their projects.

Conclusion

Akiyuki Nishimura's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…